http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#Head http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#assertion http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#provenance http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#pubinfo http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#assertion http://purl.obolibrary.org/obo/DOID_11204 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_11204 http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00741 http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association http://www.w3.org/2000/01/rdf-schema#label cortef tablets are indicated in the following conditions primary or secondary adrenocortical insufficiency hydrocortisone or cortisone is the first choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy mineralocorticoid supplementation is of particular importance as adjunctive therapy for short term administration to tide the patient over an acute episode or exacerbation in psoriatic arthritis during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus pemphigus control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment seasonal or perennial allergic rhinitis severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as allergic conjunctivitis symptomatic sarcoidosis idiopathic thrombocytopenic purpura in adults for palliative management of leukemias and lymphomas in adults to induce a diuresis or remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus to tide the patient over a critical period of the disease in ulcerative colitis acute exacerbations of multiple sclerosis tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00741 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#provenance http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#pubinfo http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig http://purl.org/nanopub/x/hasSignature FZoHTPax2uDDVQfVpl+3wAJ7KPPAAvAMQrveb3/oO9ZSN7+umeU/dxcekB3zfmHb7ZuhcW+j3dr7zrw+gT/Vf0YpI9b/VSd5nrABaAwjKt2M7dvT/BWlsxu/en3BrpKC7MeuFwSj417cniPTB6nP7XDCfVzE4jvSRTKNMo/xJ04= http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk http://purl.org/dc/terms/created 2021-06-27T19:56:47.161+02:00 http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs